Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Jun 15, 2024; 15(6): 1074-1078
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1074
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1074
Interplay of serum biomarkers bilirubin and γ-glutamyltranspeptidase in predicting cardiovascular complications in type-2 diabetes mellitus
Ebtesam Abdullah Al-Suhaimi, Scientific Research and Innovation, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia
Ebtesam Abdullah Al-Suhaimi, King Abdulaziz and his Companions Foundation for Giftedness and Creativity “Mawhiba”, Riyadh 11372, Saudi Arabia
Abdullah Ahmed Al-Rubaish, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia
Author contributions: Al-Suhaimi EA designed and drafted the first version; Al-Rubaish AA drafted and edited the second draft. All authors read and approved the final draft of the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ebtesam Abdullah Al-Suhaimi, PhD, Full Professor, Scientific Research and Innovation, Imam Abdulrahman Bin Faisal University, King Faisal Street, Coastal Road, Dammam 31441, Saudi Arabia. ealsuhaimi@iau.edu.sa
Received: December 22, 2023
Revised: April 7, 2024
Accepted: April 11, 2024
Published online: June 15, 2024
Revised: April 7, 2024
Accepted: April 11, 2024
Published online: June 15, 2024
Core Tip
Core Tip: This editorial delves into the predictive value of serum biomarkers such as bilirubin and γ-glutamyltranspeptidase in the context of type-2 diabetes mellitus with concurrent acute coronary syndrome. Highlighted findings from current research underscore the inverse correlation between these biomarkers and the incidence of major adverse cardiovascular events, advocating their utility in risk stratification and clinical management of such patients.